Market closed

LENZ Therapeutics, Inc./$LENZ

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About LENZ Therapeutics, Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Ticker

$LENZ
Trading on

Industry

Pharmaceuticals

Employees

-

LENZ Metrics

BasicAdvanced
$656M
-
-$2.34
-
-
$656M
$27.89
$16.54
295K
20.365
20.087
0.399
0.677
-25.64%
-38.94%
3.21
3.21
-8.468
-93.45%
42.50%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $LENZ

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for LENZ Therapeutics, Inc. stock?

LENZ Therapeutics, Inc. (LENZ) has a market cap of $656M as of April 19, 2025.

What is the P/E ratio for LENZ Therapeutics, Inc. stock?

The price to earnings (P/E) ratio for LENZ Therapeutics, Inc. (LENZ) stock is 0 as of April 19, 2025.

Does LENZ Therapeutics, Inc. stock pay dividends?

No, LENZ Therapeutics, Inc. (LENZ) stock does not pay dividends to its shareholders as of April 19, 2025.

When is the next LENZ Therapeutics, Inc. dividend payment date?

LENZ Therapeutics, Inc. (LENZ) stock does not pay dividends to its shareholders.

What is the beta indicator for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. (LENZ) does not currently have a Beta indicator.